Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT AMYLYX PHARMACEUTICALS, INC.

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX)
Listen to this Section


$13.29
-1.0200 ( -7.13% ) 815.1K

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder.

Market Data


Open $13.29
Previous Close $14.31
Volume 815.1K
Market Cap $1.47B
Day Range $13.26 - $14.42
52 Week Range $4.76 - $18.61
Shares Outstanding 111.19M
Change % -7.13%
Net Change ▼ -1.0200
Insider Ownership 0.00%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2022
CountryUnited States
UnderwriterGoldman Sachs, Leerink Partners, Evercore ISI, H.C. Wainwright, more

Insider Ownership Transactions

Total Amount Purchased: -3,245,337.00

Date Type Amount Purchased Purchaser
2024-09-16 Buy 40000.00 FRATES JAMES M
2024-09-09 Buy 50000.00 Firestone Karen
2024-09-05 Buy 100000.00 MILNE GEORGE M JR
2024-06-07 Sale -25000.00 Quimi Daphne
2024-06-07 Sale -25000.00 MILNE GEORGE M JR
2024-06-07 Sale -25000.00 FONTEYNE PAUL R.
2024-06-07 Sale -25000.00 Firestone Karen
2024-06-07 Sale -5753.00 Zeiher Bernhardt G
2024-05-16 Sale -10455.00 Mazzariello Gina
2024-05-16 Buy 2750.00 Quimi Daphne

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 57 Aug 07, 2025
8-k 8K-related 12 Aug 07, 2025
4 Insider transactions 1 Jun 09, 2025
4 Insider transactions 1 Jun 09, 2025
4 Insider transactions 1 Jun 09, 2025
4 Insider transactions 1 Jun 09, 2025
4 Insider transactions 1 Jun 09, 2025
8-k 8K-related 12 Jun 05, 2025

Latest News


× Before browsing our site, please accept our cookies policy